Pēd. atjaunots: 14.08.2022 17:38 (GMT+3)

InMedica 2Y 5% bond (28.06.2022)

Viļņa | First North obligāciju saraksts

INMB050023FA  |  ISIN LT0000405987

InMedica

InMedica

Name: UAB "InMedica" 
Core business: private healthcare services
Date of registration: 18 March 2004 
Auditor: UAB „Persense Audit“
Date of bond listing (First North, ISIN LT0000404246): 9 March 2020 
Date of bond listing (First North, ISIN LT0000405987): 17 February 2022
Market: Nasdaq Vilnius

Management Board
Nerijus Drobavičius (Chairman), Kęstutis Broniukaitis (Secretary), Ashwin Roy, Josifs Apts, Stella Lapina, Aleksejs Tjurkins

Background Information

“InMedica”, which after the merger with the “MediCA” group now manages the network of 77 clinics, provides diagnostic, outpatient treatment, surgical, dental and other medical services. The “InMedica” group consists of 58 family medicine centres, 6 wide-profile, 7 specialized, 6 walk-in clinics and 3 laboratories.

After the merger, the “InMedica” group now has more than 2800 employees and provides healthcare services to more than 260,000 registered patients. “INVL Baltic Sea Growth Fund”, one of the largest private equity investment funds in the Baltics, owns 45 percent of the shares in the „InMedica“ network through its subsidiary “BSGF Sanus”, 40 percent of the shares is owned by “Repharm”, the largest private medical group in Latvia, and 15 percent – by the company “Litgaja”.

Contact Details 
Address: Ozo g. 12A, LT-08200 Vilnius                    
Telephone/Fax: +370 5 265 1852 
E–mail: info@inmedica.lt
Contact person: Kęstutis Broniukaitis (CEO), +370 5 265 1852

 

Dokumenti

Dokumenti

2020
Marts

Offer Document lt, 2 MB

Vērtspapīri

Akcijas
Obligācijas
Ieguldījumu Fondi

Tirgus informācija

Statistika
Tirdzniecība
Indeksi
Izsoles

Noteikumi

Biržas noteikumi
Uzraudzība

Nāc uz Biržu

Uzņēmumiem
Investoriem
Biržas biedriem
First North konsultantiem

Aktualitātes

Nasdaq ziņas
Emitentu ziņas
Kalendārs

Par mums

Nasdaq Baltijas tirgus
Biroji